Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Boosts Universal Health Realty Trust Stake
BlackRock, Inc. reports a 14.3% beneficial ownership stake in Universal Health Realty Income Trust, holding 1,989,533 common shares.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.6% Stake in Faraday Future
BlackRock, Inc. has reported a 5.6% beneficial ownership stake in Faraday Future Intelligent Electric Inc. as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 15.2% Stake in Digi International
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 15.2% beneficial ownership stake in Digi International Inc.'s common stock.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Waterstone Financial to 7.1%
BlackRock, Inc. has reported an increased beneficial ownership of 7.1% in Waterstone Financial, Inc.'s common stock, holding 1,306,996 shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 7.2% Stake in Vertex, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.2% beneficial ownership stake in Vertex, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Hecla Mining Stake to 12.5%
BlackRock, Inc. has reported an increased beneficial ownership of 12.5% in Hecla Mining Company's common stock, totaling 84,039,884 shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Miller Industries to 7.6%
BlackRock, Inc. has reported an increased beneficial ownership of 7.6% in Miller Industries Inc., holding 866,860 shares of common stock.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Matrix Service to 12.4%
BlackRock, Inc. has increased its beneficial ownership in Matrix Service Company to 12.4% of common stock, holding 3,493,231 shares.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.01% Stake in Liberty Broadband
BlackRock, Inc. has filed a Schedule 13G, reporting a 5.01% beneficial ownership stake in Liberty Broadband Corp's Series A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.7% Stake in Garrett Motion Inc.
BlackRock, Inc. has reported a 5.7% beneficial ownership stake in Garrett Motion Inc.'s common stock, totaling 11,055,978 shares.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Lennar Stake to 7.6%
BlackRock, Inc. has reported an increased beneficial ownership of 7.6% in Lennar Corporation's Class A Stock, totaling 16,936,080 shares.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Kopin Stake to 6.7%
BlackRock, Inc. has reported an increased beneficial ownership of Kopin Corporation's common stock, now holding 6.7% of the outstanding shares.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 14.5% Stake in iShares India 50 ETF
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 14.5% beneficial ownership stake in the ISHARES INDIA 50 ETF as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock's 21.2% Stake in iShares Global Healthcare ETF
BlackRock, Inc. has reported a 21.2% beneficial ownership stake in the iShares Global Healthcare ETF, holding 9,824,389 common shares with sole voting and dispositive power.
NYSE
SCHEDULE 13G/A: BlackRock Reports 6.6% Stake in INSMED INC
BlackRock, Inc. has disclosed a 6.6% beneficial ownership stake in INSMED INC's common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.7% Stake in Hovnanian Enterprises
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 7.7% beneficial ownership of Hovnanian Enterprises Inc.'s Class A Stock, totaling 399,397 shares as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5% Stake in Hippo Holdings Inc.
BlackRock, Inc. has reported a 5.00% beneficial ownership stake in Hippo Holdings Inc., totaling 1,268,932 shares of common stock.
NYSE
SCHEDULE 13G/A: BlackRock Amends THARIMMUNE Stake Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 2.2% beneficial ownership stake in THARIMMUNE INC as of December 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in LifeCore Biomedical
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in LifeCore Biomedical, Inc., holding 1,899,903 shares of common stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.6% Stake in UiPath Class A Stock
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 8.6% of UiPath, Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Darden Restaurants Stake to 8.0%
BlackRock, Inc. has reported an 8.0% beneficial ownership stake in Darden Restaurants Inc., holding over 9.2 million common shares as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts ThredUp Stake to 7.3%
BlackRock, Inc. has reported a 7.3% beneficial ownership stake in ThredUp Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Astronics Stake to 8.7%
BlackRock, Inc. has reported an 8.7% beneficial ownership stake in Astronics Corp. common stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends DANA Inc. Stake to 14.5%
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 14.5% beneficial ownership stake in DANA Inc. common stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.8% Stake in ARKO Corp.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.8% beneficial ownership stake in ARKO Corp.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Eastman Kodak Stake Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 3.9% of Eastman Kodak Co.'s common stock.
NYSE
BlackRock, Inc. has reported a 5.1% beneficial ownership stake in Strata Critical Medical Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 9.4% Stake in Bloom Energy
BlackRock, Inc. has reported a beneficial ownership of 9.4% in Bloom Energy Corporation's Class A Stock, holding 22,345,779 shares.
NYSE
SCHEDULE 13G/A: BlackRock Boosts CACI International Stake to 8.9%
BlackRock, Inc. has reported an 8.9% beneficial ownership stake in CACI International Inc.'s Class A Stock as of December 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reports 4.4% Stake in USANA Health Sciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% beneficial ownership stake in USANA Health Sciences Inc. common stock as of December 31, 2025.